Valo

📍 Boston, United States🗓 Founded 2019👥 156 employees💰 Last funded Mar 2020
Biotechnology Research🌐 valohealth.com
Website LinkedIn
Valo is a technology company built to transform the drug discovery and development process using human-centric data and AI-powered computation. Valo is fully integrating human-centric data across the entire drug development lifecycle into a single unified architecture, thereby accelerating the discovery and development of life-changing drugs while simultaneously reducing the cost, time, and failure rate. The company’s Opal Computational Platform™ consists of an integrated set of capabilities designed to transform data into valuable insights that may accelerate discoveries and enable Valo to advance a robust pipeline of programs across cardiovascular metabolic renal, oncology, and neurodegenerative disease.
5
Total investors
3
Early stage
2
Mid stage
0
Late stage
2019
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
5
Investor activity2019–2020 · investors recorded per year
2019320202
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Valo?
Valo has 5 investors on record on gritt.io, including 3 early-stage backers, 2 mid-stage.
When did Valo last raise funding?
The most recent investment in Valo recorded on gritt.io was in March 2020.
When was Valo founded?
Valo was founded in 2019.
What industry is Valo in?
Valo operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Valo based?
Valo is headquartered in Boston, United States.